Defining a PD-specific Breath Fingerprint of Underlying Inflammatory and Neurodegenerative Processes

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions
Parkinson's Disease
Interventions
OTHER

Blood Sample Collection

Participants will have two to three tablespoons (30 cc) of peripheral blood drawn to test for inflammatory markers.

OTHER

Breath Sample Collection

Participants will be asked to breathe into the Breath Sampler containing a rapid passive volatile organic compounds (VOC) sampling device. A disposable mouthpiece is placed over a portion of the sampler where the participant placed his/her mouth. The mouthpiece will be disposed of after each use and a new one will be used for each participant. Prior to sample collection, the participant will be asked to rinse his/her mouth with water. Then the participant will breathe deeply into the sampler five times with breaths being five minutes apart to collect the alveolar breath.

Trial Locations (1)

30329

The Emory Clinic Executive Park, Atlanta

All Listed Sponsors
collaborator

Michael J. Fox Foundation for Parkinson's Research

OTHER

lead

Emory University

OTHER

NCT02749214 - Defining a PD-specific Breath Fingerprint of Underlying Inflammatory and Neurodegenerative Processes | Biotech Hunter | Biotech Hunter